Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zepvog 500mg/0.3mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Merlion Lifescience Pvt Ltd

Salt Composition

Metformin (500mg) + Voglibose (0.3mg)

Overview Zepvog 500mg/0.3mg Tablet SR

Diabexe 500mg/0.3mg Extended-Release Tablets are classified as anti-diabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabexe 500mg/0.3mg Extended-Release Tablets should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage will be determined and potentially adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation may lead to hyperglycemia and increase the risk of complications including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms part of a comprehensive diabetes management plan that necessitates adherence to a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Potential side effects include nausea, altered taste perception, appetite changes, flatulence, abdominal discomfort, diarrhea, and skin rashes. These are usually transient and self-limiting. Consult your physician if side effects persist or are concerning; management strategies may be available. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or significant hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Zepvog 500mg/0.3mg Tablet SR

Managing type 2 diabetes

Major Benefits of Zepvog 500mg/0.3mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Zepvog 500mg/0.3mg sustained-release tablet should be administered with a meal.

Common Side effects of Zepvog 500mg/0.3mg Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Zepvog 500mg/0.3mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Zepvog 500mg/0.3mg Sustained-Release Tablets with food.

How Zepvog 500mg/0.3mg Tablet SR works:

Zepvog 500mg/0.3mg extended-release tablets contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Zepvog 500mg/0.3mg SR tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Zepvog 500mg/0.3mg Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Zepvog 500mg/0.3mg tablets are likely not suitable for use while breastfeeding. Scant evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Extended-release Zepvog 500mg/0.3mg tablets typically have no impact on driving ability. Nevertheless, individuals using this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Exercise caution when administering Zepvog 500mg/0.3mg Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Zepvog 500mg/0.3mg Tablet SR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Zepvog 500mg/0.3mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is recommended.

What if you forget to take Zepvog 500mg/0.3mg Tablet SR :

Should you forget a Zepvog 500mg/0.3mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zepvog 500mg/0.3mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Zepvog 500mg/0.3mg Tablet...
65
MRP 79
17% off